Durable remission for more than 5 years with gilteritinib in FLT3-ITD-positive acute myeloid leukemia relapsing after a second allogeneic transplantation
Annals of Hematology · 06.11.2026
DOI: 10.1007/s00277-026-07347-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Hematology, online erschienen am 06.11.2026. Verfasst von Seiichiro Katagiri und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Katagiri, S., Moriyama, M., Yoshizawa, S., Chi, S., Minami, Y., & Akahane, D. (2026). Durable remission for more than 5 years with gilteritinib in FLT3-ITD-positive acute myeloid leukemia relapsing after a second allogeneic transplantation. Annals of Hematology. https://doi.org/10.1007/s00277-026-07347-9
Vancouver
Katagiri S, Moriyama M, Yoshizawa S, Chi S, Minami Y, Akahane D. Durable remission for more than 5 years with gilteritinib in FLT3-ITD-positive acute myeloid leukemia relapsing after a second allogeneic transplantation. Annals of Hematology. 2026. doi:10.1007/s00277-026-07347-9
BibTeX
@article{Katagiri2026,
author = {Katagiri, Seiichiro and Moriyama, Mitsuru and Yoshizawa, Seiichiro and Chi, SungGi and Minami, Yosuke and Akahane, Daigo},
title = {Durable remission for more than 5 years with gilteritinib in FLT3-ITD-positive acute myeloid leukemia relapsing after a second allogeneic transplantation},
journal = {Annals of Hematology},
year = {2026},
doi = {10.1007/s00277-026-07347-9}
}
EUVIMED